As of 2026-09-15, the Relative Valuation of Dechra Pharmaceuticals PLC (DPH.L) is (424.58) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC based on Relative Valuation is -111.0%.
The range of the Relative Valuation is (399.46) - (441.61) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.1x - 18.0x | 16.9x |
| Forward P/E multiples | 16.3x - 19.1x | 17.8x |
| Fair Price | (399.46) - (441.61) | (424.58) |
| Upside | -110.3% - -111.4% | -111.0% |
| Date | P/E |